• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病(AD)大脑中早期β-淀粉样蛋白(Aβ)积累以及进行性突触丧失、胶质细胞增生和缠结形成。

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.

作者信息

Ingelsson M, Fukumoto H, Newell K L, Growdon J H, Hedley-Whyte E T, Frosch M P, Albert M S, Hyman B T, Irizarry M C

机构信息

Harvard Medical School, Massachusetts General Hospital, Boston.

出版信息

Neurology. 2004 Mar 23;62(6):925-31. doi: 10.1212/01.wnl.0000115115.98960.37.

DOI:10.1212/01.wnl.0000115115.98960.37
PMID:15037694
Abstract

BACKGROUND

Pathologic changes in the Alzheimer disease (AD) brain occur in a hierarchical neuroanatomical pattern affecting cortical, subcortical, and limbic regions.

OBJECTIVE

To define the time course of pathologic and biochemical changes-amyloid deposition, amyloid beta-peptide (Abeta) accumulation, neurofibrillary tangle (NFT) formation, synaptic loss, and gliosis-within the temporal association cortex of AD cases of varying disease duration, relative to control brains.

METHODS

Stereologic assessments of amyloid burden and tangle density as well as ELISA-based measurements of Abeta, synaptophysin, and glial fibrillary acidic protein (GFAP) were performed in the superior temporal sulcus from a cohort of 83 AD and 26 nondemented control brains.

RESULTS

Relative to control cases, AD brains were characterized by accumulation of NFT and amyloid plaques, increase of tris- and formic acid-extractable Abeta species, reduced levels of synaptophysin, and elevated levels of GFAP. In AD cases, the duration of dementia correlated with the degree of tangle formation, gliosis, and synaptic loss but not with any Abeta measures. Accumulation of Abeta, measured both neuropathologically and biochemically, was markedly increased in AD brains independent of disease duration, even in cases of short duration.

CONCLUSIONS

These data support distinct processes in the initiation and progression of AD pathology within the temporal cortex: Deposition of Abeta reaches a "ceiling" early in the disease process, whereas NFT formation, synaptic loss, and gliosis continue throughout the course of the illness.

摘要

背景

阿尔茨海默病(AD)大脑中的病理变化呈分层的神经解剖学模式,影响皮质、皮质下和边缘区域。

目的

确定不同病程的AD病例颞叶联合皮质内病理和生化变化(淀粉样蛋白沉积、淀粉样β肽(Aβ)积累、神经原纤维缠结(NFT)形成、突触丧失和胶质细胞增生)的时间进程,并与对照大脑进行比较。

方法

对83例AD患者和26例非痴呆对照者大脑的颞上沟进行淀粉样蛋白负荷和缠结密度的体视学评估,以及基于酶联免疫吸附测定法(ELISA)检测Aβ、突触素和胶质纤维酸性蛋白(GFAP)。

结果

与对照病例相比,AD大脑的特征为NFT和淀粉样斑块积累、三氟乙酸和甲酸可提取的Aβ种类增加、突触素水平降低以及GFAP水平升高。在AD病例中,痴呆持续时间与缠结形成、胶质细胞增生和突触丧失程度相关,但与任何Aβ检测指标无关。无论是通过神经病理学还是生物化学方法检测,Aβ的积累在AD大脑中均显著增加,且与疾病持续时间无关,即使是病程较短的病例也是如此。

结论

这些数据支持AD病理在颞叶皮质起始和进展过程中的不同过程:Aβ沉积在疾病过程早期达到“上限”,而NFT形成、突触丧失和胶质细胞增生在疾病全过程中持续存在。

相似文献

1
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.阿尔茨海默病(AD)大脑中早期β-淀粉样蛋白(Aβ)积累以及进行性突触丧失、胶质细胞增生和缠结形成。
Neurology. 2004 Mar 23;62(6):925-31. doi: 10.1212/01.wnl.0000115115.98960.37.
2
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.可溶性淀粉样β肽浓度作为阿尔茨海默病突触变化的预测指标。
Am J Pathol. 1999 Sep;155(3):853-62. doi: 10.1016/s0002-9440(10)65184-x.
3
Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.在未患痴呆症的老年受试者的额叶联合皮质中,载脂蛋白Eε4基因增强的阿尔茨海默β淀粉样蛋白沉积先于神经原纤维病变出现。
J Neuropathol Exp Neurol. 2001 Jul;60(7):731-9. doi: 10.1093/jnen/60.7.731.
4
Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.神经病理学定义的阿尔茨海默病亚型与以神经纤维缠结为主的痴呆症有显著差异。
Acta Neuropathol. 2012 Nov;124(5):681-92. doi: 10.1007/s00401-012-1044-y. Epub 2012 Sep 12.
5
Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.淀粉样β和 tau 的组合模型揭示了淀粉样沉积物和缠结形成之间的协同作用。
Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12779. doi: 10.1111/nan.12779. Epub 2021 Dec 10.
6
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
7
Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.进行性核上性麻痹中星形胶质细胞内的tau蛋白积累是一个变性过程而非反应性过程。
Acta Neuropathol. 2002 Oct;104(4):398-402. doi: 10.1007/s00401-002-0569-x. Epub 2002 May 30.
8
Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.生物标志物、酮体与阿尔茨海默病的预防。
Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30.
9
Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.阿尔茨海默病中的氧化平衡:与 APOE、Braak 缠结阶段以及可溶性和不溶性淀粉样蛋白-β浓度的关系。
J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.
10
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.
Neurobiol Aging. 1997 Jan-Feb;18(1):121-7. doi: 10.1016/s0197-4580(96)00204-7.

引用本文的文献

1
Therapeutic Effects of Neuro-Cells on Amyloid Pathology, BDNF Levels, and Insulin Signalling in APPswe/PSd1E9 Mice.神经细胞对APPswe/PSd1E9小鼠淀粉样病理、脑源性神经营养因子水平及胰岛素信号传导的治疗作用
Cells. 2025 Aug 20;14(16):1293. doi: 10.3390/cells14161293.
2
Systemic inflammation as a central player in the initiation and development of Alzheimer's disease.全身炎症是阿尔茨海默病发生和发展的核心因素。
Immun Ageing. 2025 Aug 21;22(1):33. doi: 10.1186/s12979-025-00529-5.
3
Neuro-Cells Mitigate Amyloid Plaque Formation and Behavioral Deficits in the APPswe/PS1dE9 Model of Alzheimer Disease While Also Reducing IL-6 Production in Human Monocytes.
神经细胞可减轻阿尔茨海默病APPswe/PS1dE9模型中的淀粉样斑块形成和行为缺陷,同时还能减少人类单核细胞中的白细胞介素-6生成。
Cells. 2025 Jul 29;14(15):1168. doi: 10.3390/cells14151168.
4
Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.阿尔茨海默病动物模型中突触前蛋白的蛋白质组学和非蛋白质组学变化:2015 - 2023年的一项荟萃分析
J Alzheimers Dis. 2025 Aug 1;107(2):13872877251362212. doi: 10.1177/13872877251362212.
5
Interplay Between Aging and Tau Pathology in Alzheimer's Disease: Mechanisms and Translational Perspectives.阿尔茨海默病中衰老与 Tau 病理的相互作用:机制与转化视角
Antioxidants (Basel). 2025 Jun 24;14(7):774. doi: 10.3390/antiox14070774.
6
The Potential for Neuromodulation in the Treatment of Alzheimer's Disease: A Review of Clinical Trials.神经调节在阿尔茨海默病治疗中的潜力:临床试验综述
Cureus. 2025 May 31;17(5):e85156. doi: 10.7759/cureus.85156. eCollection 2025 May.
7
Elevated BACE1 mRNA Level is Associated with Lower miR-15a-5p and miR-19b-3p Expressions in Peripheral Blood Mononuclear Cells of Patients with Late-Onset Alzheimer's Disease: Wet Lab Results and Bioinformatics Analysis.晚发性阿尔茨海默病患者外周血单个核细胞中BACE1 mRNA水平升高与miR-15a-5p和miR-19b-3p表达降低相关:实验结果与生物信息学分析
Mol Neurobiol. 2025 Jun 27. doi: 10.1007/s12035-025-05159-y.
8
An Overview of Glutaminyl Cyclase as a Promising Drug Target for Alzheimer's Disease.谷氨酰胺环化酶作为阿尔茨海默病潜在药物靶点的概述。
Biomedicines. 2025 Jun 13;13(6):1467. doi: 10.3390/biomedicines13061467.
9
Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model.在人源tau蛋白病芯片模型中,星形胶质细胞驱动的血管收缩会损害类淋巴系统清除功能。
APL Bioeng. 2025 Jun 16;9(2):026126. doi: 10.1063/5.0261875. eCollection 2025 Jun.
10
Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer's and Parkinson's disease.海马亚区:阿尔茨海默病和帕金森病中的体积、神经病理学易损性及认知衰退
Alzheimers Res Ther. 2025 May 30;17(1):121. doi: 10.1186/s13195-025-01768-w.